WO1999014202A2 - Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide - Google Patents

Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide Download PDF

Info

Publication number
WO1999014202A2
WO1999014202A2 PCT/EP1998/005790 EP9805790W WO9914202A2 WO 1999014202 A2 WO1999014202 A2 WO 1999014202A2 EP 9805790 W EP9805790 W EP 9805790W WO 9914202 A2 WO9914202 A2 WO 9914202A2
Authority
WO
WIPO (PCT)
Prior art keywords
propyl
butyl
alkyl
mono
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1998/005790
Other languages
English (en)
French (fr)
Other versions
WO1999014202B1 (en
WO1999014202A3 (en
Inventor
Harald Walter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH Austria
Novartis AG
Original Assignee
Novartis Erfindungen Verwaltungs GmbH
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfindungen Verwaltungs GmbH, Novartis AG filed Critical Novartis Erfindungen Verwaltungs GmbH
Priority to BR9812439-0A priority Critical patent/BR9812439A/pt
Priority to US09/508,307 priority patent/US6277858B1/en
Priority to JP2000511753A priority patent/JP2001516749A/ja
Priority to NZ503261A priority patent/NZ503261A/en
Priority to DE69804981T priority patent/DE69804981T2/de
Priority to AT98951380T priority patent/ATE216370T1/de
Priority to CA002301694A priority patent/CA2301694A1/en
Priority to PL98339053A priority patent/PL339053A1/xx
Priority to IL13477998A priority patent/IL134779A0/xx
Priority to AU97429/98A priority patent/AU743717B2/en
Priority to DK98951380T priority patent/DK1015434T3/da
Priority to KR1020007002578A priority patent/KR100585571B1/ko
Priority to EP98951380A priority patent/EP1015434B1/en
Publication of WO1999014202A2 publication Critical patent/WO1999014202A2/en
Publication of WO1999014202A3 publication Critical patent/WO1999014202A3/en
Publication of WO1999014202B1 publication Critical patent/WO1999014202B1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/541,3-Diazines; Hydrogenated 1,3-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/90Oxygen atoms with acyclic radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/92Oxygen atoms with hetero atoms directly attached to nitrogen atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Definitions

  • the present invention relates to novel pyrimidin-4-one and pyrimidin-4-thione derivatives of formula I, which have pesticidal activity, in particular fungicidal activity,
  • A is phenyl, thienyl (including all 3 isomers), thiazolyl, pyridyl or pyridazinyl;
  • X is oxygen or sulfur
  • R is hydrogen, halogen or trimethylsilyl
  • R 2 is hydrogen, halogen or trimethylsilyl; at least one of Rj and R 2 is not hydrogen;
  • R 3 is C,-C 8 alkyl, which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen, CrC 6 alkoxy or CrC 6 haloalkoxy; O-C ⁇ -C 6 alkyl, O-C 2 -C 6 alkenyl,
  • R 4 is C,-C 8 alkyl, C ⁇ C g alkenyl, C,-C 8 alkinyl which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen, cyano, d-Cealkoxy or CrC 6 haloalkoxy; d-C 4 alkoxy-
  • the invention also relates to the preparation of these compounds, to agrochemical compositions comprising as active ingredient at least one of these compounds, as well as to the use of the active ingredients or compositions for pest control, in particular as fungicides, in agriculture and horticulture.
  • the compounds I and, optionally, their tautomers may be obtained in the form of their salts. Because the compounds I have at least one basic center they can, for example, form acid addition salts.
  • Said acid addition salts are, for example, formed with mineral acids, typically sulfuric acid, a phosphoric acid or a hydrogen halide, with organic carboxylic acids, typically acetic acid, oxalic acid, malonic acid, maleic acid, fumaric acid or phthalic acid, with hydroxycarboxylic acids, typically ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or with benzoic acid, or with organic sulfonic acids, typically methanesulfonic acid or p-toluenesulfonic acid.
  • the compounds of formula I can also form salts with bases.
  • Suitable salts with bases are, for example, metal salts, typically alkali metal salts or alkaline earth metal salts, e.g. sodium salts, potassium salts or magnesium salts, or salts with ammonia or an organic amine, e.g. morpholine, piperidine, pyrrolidine, a mono-, di- or trialkylamine, typically ethylamine, diethylamine, triethylamine or dimethylpropylamine, or a mono-, di- or trihydroxyalkylamine, typically mono-, di- or triethanolamine.
  • agrochemical acceptable salts are preferred.
  • asymmetrical carbon atoms are present in the compounds of formula I, these compounds are in optically active form. Owing to the presence of double bonds, the compounds can be obtained in the [E] and/or [Z] form. Atropisomerism can also occur.
  • the invention relates to the pure isomers, such as enantiomers and diastereomers, as well as to all possible mixtures of isomers, e.g. mixtures of diastereomers, racemates or mixtures of racemates.
  • Alkyl groups on their own or as structural element of other groups such as alkoxy are, in accordance with the number of carbon atoms, straight-chain or branched and will typically be methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-amyl, tert-amyl, 1 -hexyl, 3-hexyl, 1 -heptyl or 1 -octyl.
  • Alkenyl will be understood as meaning straight-chain or branched alkenyl such as allyl, methallyl, 1-methylvinyl, but-2-en-1 -yl, 1 -pentenyl, 1 -hexenyl, 1 -heptenyl or 1 -octenyl.
  • Preferred alkenyl radicals contain 3 to 4 carbon atoms in the chain.
  • Alkynyl can likewise, in accordance with the number of carbon atoms, be straight-chain or branched and is typically propargyl, but-1-yn-1-yl, but-1-yn-3-yl, 1-pentinyl, 1-hexinyl, 1- heptinyl or 1 -octinyl. The preferred meaning is propargyl.
  • Halogen and halo substituents will be understood generally as meaning fluorine, chlorine, bromine or iodine. Fluorine, chlorine or bromine are preferred meanings.
  • Haloalkyl can contain identical or different halogen atoms, typically fluoromethyl, difluoro- methyl, difluorochloromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, 2,2,2-trichloroethyl, 3,3,3-trifluoropropyl.
  • halogen atoms typically fluoromethyl, difluoro- methyl, difluorochloromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, 2,2,2-trichloroethyl, 3,3,3-trifluoropropyl.
  • Cycloalkyi is, depending on the ring size, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cycooctyl.
  • Preferred compounds are those of formula I, wherein A is thienyl, including all 3 isomers (subgroup A).
  • Ri is hydrogen, fluorine, chlorine, bromine or iodine
  • R 2 is hydrogen, fluorine, chlorine, bromine or iodine; at least one of RT and R 2 is not hydrogen;
  • R 4 is C,-C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkinyl which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen or d-C 4 alkyoxy; or phenyl which is unsubstituted or mono to tri- substituted by fluorine, chlorine, bromine, C C 4 alkyl, C ⁇ -C 4 haloalkyl, C ⁇ -C 4 alkoxy, CrC 4 haloalkoxy, phenyl or phenoxy and in which the phenyl part is unsubstituted or mono to tri-substituted by fluorine, chlorine, bromine, C,-C 4 alkyl, C ⁇ -C haloalkyl, C C 4 alkoxy or C C 4 haloalkoxy (subgroup B).
  • R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkinyl which are unsubstituted or mono to tri-substituted by C 3 -C 4 cycloalkyl, fuorine, chlorine, bromine or d-C 4 alkoxy; or phenyl which is unsubstituted or mono to tri-substituted by fluorine, chlorine, bromine, CrC 4 alkyl, d-C 4 haloalkyl, d-C 4 alkoxy, d-C haloalkoxy, phenyl or phenoxy and in which the phenyl part is unsubstituted or mono to tri-substituted by fluorine, chlorine or bromine (subgroup C).
  • A is thienyl[2.3-d]
  • Rt is hydrogen, chlorine or bromine
  • R 2 is hydrogen, chlorine or bromine; at least one of Ri and R 2 is not hydrogen;
  • R 3 is C 3 -C 5 alkyl or O-d-C 4 alkyl
  • R 4 is C 2 -C 5 alkyl or phenyl which is unsubstituted or mono to tri-substituted by fluorine, chlorine, bromine, d-C alkyl or phenoxy and in which the phenoxy is unsubstituted or mono to tri-substituted by fluorine, chlorine or bromine (subgroup D1 ).
  • A is thienyl[2.3-d]
  • X is sulfur
  • R is hydrogen, chlorine or bromine
  • R 2 is hydrogen, chlorine or bromine; at least one of Ri and R 2 is not hydrogen;
  • R 3 is C 3 -C 5 alkyl or O-d-C 4 alkyl
  • R 4 is C 2 -C 5 alkyl or phenyl which is unsubstituted or mono to tri-substituted by fluorine, chlorine, bromine, C,-C 4 alkyl or phenoxy and in which the phenoxy is unsubstituted or mono to tri-substituted by fluorine, chlorine or bromine (subgroup D2).
  • Another preferred group within the scope of subgroup C is that of the compounds of the formula I, wherein A is thienyl[3.2-d],
  • Rj is hydrogen, chlorine or bromine
  • R 2 is hydrogen, chlorine or bromine; at least one of Ri and R 2 is not hydrogen;
  • R 3 is C 3 -C 5 alkyl or O-C C 4 alkyl
  • R is C 2 -C 5 alkyl or phenyl which is unsubstituted or mono to tri-substituted by fluorine, chlorine, bromine, d-C alkyl or phenoxy and in which the phenoxy is unsubstituted or mono to tri-substituted by fluorine, chlorine or bromine (subgroup E).
  • Another preferred group of compounds are those of formula I, wherein A is pyridyl (subgroup F).
  • Ri is hydrogen, fluorine, chlorine, bromine or iodine
  • R is hydrogen, fluorine, chlorine, bromine or iodine; at least one of R and R 2 is not hydrogen;
  • R 3 is C j -Cealkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkinyl which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen or d-C 4 alkoxy; O-d-C 6 alkyl, O-C 2 -C 6 alkenyl, O-C 2 -C 6 alkynyl, which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen or d-dalkoxy;
  • R 4 is C ⁇ Cealkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkinyl which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen or d-C 4 alkoxy; or phenyl which is unsubstituted or mono to tri- substituted by fluorine, chlorine, bromine, d-C alkyl, d-C 4 haioalkyl, d-C alkoxy, d-dhaloalkoxy, phenyl or phenoxy and in which the phenyl part is unsubstituted or mono to tri-substituted by fluorine, chlorine, bromine, d-dalkyl, d-C 4 haloalkyl, d-dalkoxy or C ⁇ -C 4 haloalkoxy (subgroup G).
  • R 2 is hydrogen, fluorine, chlorine, bromine or iodine; at least one of Ri and R 2 is not hydrogen;
  • R 4 is C ⁇ dalkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkinyl which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen or C ⁇ -C alkoxy; or phenyl which is unsubstituted or mono to tri- substituted by fluorine, chlorine, bromine, d-C 4 alkyl, C C haloalkyl, C ⁇ -C 4 alkoxy, d-dhaloalkoxy, phenyl or phenoxy and in which the phenyl part is unsubstituted or mono to tri-substituted by fluorine, chlorine, bromine, d-C 4 alkyl, d-C haloalkyl, d-dalkoxy or d-dhaloalkoxy (subgroup J1).
  • Another preferred group within the scope of subgroup H is that of compounds of the formula I, wherein X is sulfur;
  • R is hydrogen, fluorine, chlorine or bromine
  • R 2 is hydrogen, fluorine, chlorine or bromine; at least one of R and R 2 is not hydrogen;
  • R 3 is C,-C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkinyl which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen or d-C 4 alkoxy;
  • R 4 is C,-C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkinyl which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen or d-C 4 alkoxy; or phenyl which is unsubstituted or mono to tri- substituted by fluorine, chlorine, bromine, C ⁇ -C 4 alkyl, d-C 4 haloalkyl, d-C alkoxy, C ⁇ -C haloalkoxy, phenyl or phenoxy and in which the phenyl part is unsubstituted or mono to tri-substituted by fluorine, chlorine, bromine, d-C 4 alkyl, d-C 4 haloalkyl, d-dalkoxy or d-dhaloalkoxy (subgroup J2).
  • Rj is hydrogen, fluorine, chlorine, bromine or iodine
  • R is hydrogen, fluorine, chlorine, bromine or iodine; at least one of R and R 2 is not hydrogen;
  • R 3 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkinyl which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen or C ⁇ -C 4 alkoxy; O-d-C 6 alkyl, O-C 2 -C 6 alkenyl, O-C 2 -C 6 alkynyl, which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen or C ⁇ -C 4 alkoxy;
  • R 4 is C,-C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkinyi which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen or d-C 4 alkoxy; or phenyl which is unsubstituted or mono to tri- substituted by fluorine, chlorine, bromine, C C 4 alkyl, d-C 4 haloalkyl, d-C alkoxy, C,-C 4 haloalkoxy, phenyl or phenoxy and in which the phenyl part is unsubstituted or mono to tri-substituted by fluorine, chlorine, bromine, d-dalkyi, d-C 4 haloalkyl, d-C 4 alkoxy or d-dhaloalkoxy (subgroup L).
  • Another preferred group of compounds are those of formula I, wherein A is pyridazinyl (subgroup M).
  • Rj is hydrogen, fluorine, chlorine, bromine or iodine
  • R 2 is hydrogen, fluorine, chlorine, bromine or iodine; at least one of R and R 2 is not hydrogen;
  • R 3 is C,-C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkinyl which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen or d-C alkoxy; O-d-C 6 alkyl, O-C 2 -C 6 alkenyl, O-C 2 -C 6 alkynyl, which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen or d-dalkoxy;
  • R 4 is C,-C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkinyl which are unsubstituted or mono to tri-substituted by C 3 -C 6 cycloalkyl, halogen or d-C 4 alkoxy; or phenyl which is unsubstituted or mono to tri- substituted by fluorine, chlorine, bromine, d-C 4 alkyl, d-C 4 haloalkyl, C,-C 4 alkoxy, d-dhaloalkoxy, phenyl or phenoxy and in which the phenyl part is unsubstituted or mono to tri-substituted by fluorine, chlorine, bromine, d-C alkyl, C,-C 4 haloalkyl, d-C 4 alkoxy or Cj-C haloalkoxy (subgroup N).
  • the methyl th ⁇ ophene-2-am ⁇ no-3-carboxy- late can be prepared, for example, in accordance with Acta Pharm. Suecica 1968. Vol. 5, p.563, according to S.Gronowitz et al.
  • Other heterocycles can be prepared according to instructions in the literature.
  • step 1 in scheme 1 The reaction of the ⁇ -amino- ⁇ -carboalkoxyheterocycles or ⁇ - amino- ⁇ -carbocychc acid heterocycles with amides (R CONHR 3 ) (step 1 in scheme 1 ) is conveniently carried out in the presence of POCI 3 , SOCI 2 or SO 2 CI 2 , in solvents, such as CICH 2 CH 2 CI, CHCI 3 , CH 2 CI 2 , benzene, toluene, hexane, cyclohexane or others in the temperature range from RT to reflux temperature.
  • solvents such as CICH 2 CH 2 CI, CHCI 3 , CH 2 CI 2 , benzene, toluene, hexane, cyclohexane or others in the temperature range from RT to reflux temperature.
  • the resulting amidines (III) either cyclise spontaneously to the pyr ⁇ m ⁇ d ⁇ n-4-ones or were converted into the cychsed products by treatment with bases such as t-Butyl-O-K, NaH, KH, n-BuLi, NaOH, Na 2 CO 3 or others in solvents such as THF, dioxane, hexane, toluene, DMSO, DMF, dimethylacetamid or others at temperatures between 20°C and reflux-temperature.
  • bases such as t-Butyl-O-K, NaH, KH, n-BuLi, NaOH, Na 2 CO 3 or others in solvents such as THF, dioxane, hexane, toluene, DMSO, DMF, dimethylacetamid or others at temperatures between 20°C and reflux-temperature.
  • step 3 in scheme 1 The replacement of the 4-one group with sulfur to the 4-thione group (step 3 in scheme 1 ) is carried out by reaction with P 2 S 5 or Lawesson-reagent in tetrahydrofurane, dioxane or toluene as solvent in the temperature range of RT to reflux temperature.
  • the invention also relates to the intermediates of the formula III, IV and V, and especially to those wherein A represents thienyl[2.3-d].
  • radicals Rj or R 2 indicated above can be introduced by reacting the resulting anions with electrophiles (step 1 in scheme 2), typically Br 2 , NBS, F 2 , ICl, Cl 2 , F * reagents, trimethylsilyl chloride.
  • E + j 2 NBS (N-Bromsuccinimide), NCS (N-Chiorsuccinimide), l 2 , Cl 2 , Br 2 , FCI, F + reagents, TMS and similar Si reagents.
  • the following compounds can likewise be prepared in general accordance with the methods described in scheme 2:
  • N-bromosuccinimide or N-chlorosuccinimide or Cl 2 gas or Br 2 ) are used for halogenation.
  • the solvent used is, for example, pyridine in the temperature range from 0°C to reflux.
  • the reaction time is 1 to 24 hours.
  • the described reactions are carried out in per se known manner, e.g. in the presence or absence of a suitable solvent or diluent or of a mixture thereof, if appropriate with cooling, at room temperature or with heating, e.g. in the temperature range from about -20°C to the boiling temperature of the reaction medium, preferably in the range from about -20°C to about +150°C and, if required, in a closed vessel, under pressure, in an inert gas atmosphere and/or under anhydrous conditions.
  • solvents or diluents are: aromatic, aliphatic and aiicyclic hydrocarbons and halogenated hydrocarbons, typically benzene, toluene, xylene, chlorobenzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, trichloromethane, dichloroethane or trichioroethane; ethers, typically diethyl ether, tert-butylmethyl ether, tetrahydrofuran or dioxane; ketones, typically acetone or methyl ethyl ketone; alcohols, typically methanol, ethanoi, propanol, butanol, ethylene glycol or glycerol; esters, typically ethyl acetate or butyl acetate; amides, typically N,N-dimethylformamide, N,N-dimethylace
  • Suitable bases are, for example, alkali metal hydroxide or alkaline earth metal hydroxide, alkali metal hydride or alkaline earth metal hydride, alkali metal amide or alkaline earth metal amide, alkali metal alkanolate or alkaline earth metal alkanolate, alkali metal carbonate or alkaline earth metal carbonate, alkali metal dialkylamide or alkaline earth metal dialkylamide, or alkali metal alkylsilylamide or alkaline earth metal alkylsilylamide, alkyl- amines, alkylenediamines, optionally N-alkylated, optionally unsaturated cycloalkylamines, basic heterocycles, ammonium hydroxides and carbocyclic amines.
  • DBU 1 ,8-diazabicyclo[5.4.0]undec-5-ene
  • the compounds of the formula I can also be prepared as follows
  • R 5 C r C 6 -alkyl
  • the amino carboxylic acidamide of formula VI reacts with the orthoester of formula XIII in the presence or absence of a suitable solvent or diluent, if required in the presence of an acid catalyst at room temperature or with heating, e.g. in the temperature range from about 20 to 200°C.
  • solvents or diluents are ethers like tert.butylmethylether, tetrahydrofurane, dimethylether; amides like N,N-dimethylformam ⁇ de or N-methyl-pyrrolidone; sulfoxides, typically dimethylsulfoxid and alcohols like methanol, ethanoi, propanol, butanol, ethylene glycol or glycerol.
  • catalyst can be used hydrogen halides, methanesulfonic acid, triflouromethyl aceticacid, p-toluenesulfonic acid and others in the absence of water.
  • bases are sodium hydroxid, potassium hydroxid, sodium hydrogencarbonate, sodium carbonate, sodium hydride, potassium hydride, potassium carbonate and others.
  • scheme 5 describes the reaction of the aminothiophene-carboxylic-acid amide Via with the orthoester XIII in the presence or absence of a solvent, if required in the presence of an acid catalyst in the temperature range from 20 to 200°C.
  • the resulting intermediate Vila is then halogenated in the presence of a solvent at temperatures from 20°C to reflux.
  • the halogenated intermediate Villa is than cyclised in the presence of a base, in the presence or absence of a suitable solvent at temperatures from 20°C to reflux.
  • Halogenation reagents are typically N- Bromsuccinimide, N-Chlorsuccinimide, N-iodsuccinimide, Chlorgas, Br , thionylchloride and others.
  • solvents used for the halogenation are tert.-butylmethylether, tetrahydrofurane, chloroform, methylenechloride, pyridine and quinoline.
  • Hal + NCS, NBS, NIS, Cl 2 , Br 2 S0 2 CI 2 solvents for halogenation: THF, TBME, CHCI3, CH 2 CI 2 pyridine, quinoline and others
  • Scheme 6 Another alternative is described in scheme 6, in which the amino-carboalkoxy-thiophene of formula lla reacts with the orthoester XIII to the intermediate IXa, than the compound IXa is transformed to the amidine Ilia and cyclised to the thienopyrimidinone X.
  • the halogenation of X to obtain 1.1 is as described in Scheme 3.
  • R 6 C r C 8 -alkyl
  • reaction conditions from lla to IXa is as described in the schemes 4 or 5, as well as the cyclisation from Ilia to X is as described above.
  • the reaction from IXa to Ilia requires as solvent for example tetrahydrofurane, N,N-dimethylformamide or others at a temperature range from 0°C to reflux.
  • Scheme 8 describes the alternative route comprising the reaction of the compound lla with the orthoester XIII to the intermediate IXa, which is halogenated to the intermediate Xlla and than converted to the thiophene Xla. Cyclisation of Xla gives the end product 1.1 .
  • the reactions conditions are as described in the schemes 4, 5, 6 and 7.
  • Quinazolinone derivatives having fungicidal properties are known from WO-94/26722 or EP-A-276825 and thienopyrimidinones are known from WO-97/02262.
  • novel compounds of formula I have, for practical purposes, a very advantageous spectrum of activities for protecting plants against diseases that are caused by fungi as well as by bacteria and viruses.
  • the compounds of formula I can be used in the agricultural sector and related fields as active ingredients for controlling plant pests.
  • the novel compounds are distinguished by excellent activity at low rates of application, by being well tolerated by plants and by being environmentally safe. They have very useful curative, preventive and systemic properties and are used for protecting numerous cultivated plants.
  • the compounds of formula I can be used to inhibit or destroy the pests that occur on plants or parts of plants (fruit, blossoms, leaves, stems, tubers, roots) of different crops of useful plants, while at the same time protecting also those parts of the plants that grow later e.g. from phytopathogenic microorganisms.
  • compounds of formula I as dressing agents for the treatment of plant propagation material, in particular of seeds (fruit, tubers, grains) and plant cuttings (e.g. rice), for the protection against fungal infections as well as against phytopathogenic fungi occurring in the soil.
  • the compounds I are, for example, effective against the phytopathogenic fungi of the following classes: Fungi imperfecti (e.g. Botrytis, Pyricularia, Helminthosporium, Fusarium, Septoria, Cercospora and Alternaria) and Basidiomycetes (e.g. Rhizoctonia, Hemileia, Puccinia). Additionally, they are also effective against the Ascomycetes classes (e.g. Ven- turia and Erysiphe, Podosphaera, Moniiinia, Uncinula) and of the Oomycetes classes (e.g. Phytophthora, Pythium, Plasmopara).
  • Fungi imperfecti e.g. Botrytis, Pyricularia, Helminthosporium, Fusarium, Septoria, Cercospora and Alternaria
  • Basidiomycetes e.g. Rhizoctonia, Hemileia, Puccinia
  • novel compounds of formula I are effective against phytopathogenic bacteria and viruses (e.g. against Xanthomonas spp, Pseudomonas spp, Erwinia amylovora as well as against the tobacco mosaic virus).
  • target crops to be protected typically comprise the following species of plants: cereal (wheat, barley, rye, oat, rice, maize, sorghum and related species); beet (sugar beet and fodder beet); pomes, drupes and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and blackberries); leguminous plants (beans, lentils, peas, soybeans); oil plants (rape, mustard, poppy, olives, sunflowers, coconut, castor oil plants, cocoa beans, groundnuts); cucumber plants (pumpkins, cucumbers, melons); fibber plants (cotton, flax, hemp, jute); citrus fruit (oranges, lemons, grapefruit, mandarins); vegetables (spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, paprika); lauraceae (avocado, cinnamomum, camphor) or plants such
  • the compounds of formula I are normally used in the form of compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession with further compounds.
  • further compounds can be e.g. fertilizers or micronutrient donors or other preparations which influence the growth of plants. They can also be selective herbicides as well as insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application promoting adjuvants customarily employed in the art of formulation.
  • the compounds of formula I can be mixed with other fungicides, resulting in some cases in unexpected synergistic activities.
  • azoles such as azaconazole, bitertanol, propiconazole, difenoconazole, diniconazole, cyproconazole, epoxiconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imazalil, imibenconazole, ipconazole, tebuconazole, tetraconazole, fenbuconazole, metconazole, myclobutanil, perfurazoate, penconazole, bromuconazole, pyrifenox, prochloraz, triadimefon, triadimenol, triflumizole or triticonazole; pyrimidinyl carbinoles such as ancymidol, fenarimol or nuarimol; 2-amino- pyrimidine such as bupirimate, dimethirimol or ethir
  • Preferred compound for mixing with the above-mentioned mixing components is compound no. 3.30.
  • Another preferred compound for mixing with the above-mentioned mixing components is compound no. 3.31 .
  • Another preferred compound for mixing with the above-mentioned mixing components is compound no. 3.58.
  • Another preferred compound for mixing with the above-mentioned mixing components is compound no. 3.59.
  • Suitable carriers and adjuvants can be solid or liquid and are substances useful in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers.
  • a preferred method of applying a compound of formula I, or an agrochemical composition which contains at least one of said compounds, is foliar application.
  • the frequency of application and the rate of application will depend on the risk of infestation by the corresponding pathogen.
  • the compounds of formula I can also penetrate the plant through the roots via the soil (systemic action) by drenching the locus of the plant with a liquid formulation, or by applying the compounds in solid form to the soil, e.g. in granular form (soil application). In crops of water rice such granulates can be applied to the flooded rice field.
  • the compounds of formula I may also be applied to seeds (coating) by impregnating the seeds or tubers either with a liquid formulation of the fungicide or coating them with a solid formulation.
  • the compounds of formula I are used in unmodified form or, preferably, together with the adjuvants conventionally employed in the art of formulation. To this end they are conveniently formulated in known manner to emulsifiable concentrates, coatable pastes, directly sprayable or dilutable solutions, dilute emulsions, wettable powders, soluble powders, dusts, granulates, and also encapsulations e.g. in polymeric substances.
  • the methods of application such as spraying, atomizing, dusting, scattering, coating or pouring, are chosen in accordance with the intended objectives and the prevailing circumstances.
  • Advantageous rates of application are normally from 5 g to 2 kg of active ingredient (a.i.) per hectare (ha), preferably from 10 g to 1 kg a.i./ha, most preferably from 20 g to 600 g a.i./ha.
  • convenient dosages are from 10 mg to 1 g of active substance per kg of seeds.
  • compositions containing the compound of formula I and, if desired, a solid or liquid adjuvant are prepared in known manner, typically by intimately mixing and/or grinding the compound with extenders, e.g. solvents, solid carriers and, optionally, surface active compounds (surfactants).
  • extenders e.g. solvents, solid carriers and, optionally, surface active compounds (surfactants).
  • Suitable carriers and adjuvants may be solid or liquid and correspond to the substances ordinarily employed in formulation technology, such as, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, thickeners binding agents or fertilizers. Such carriers are for example described in WO 97/33890.
  • the agrochemical formulations will usually contain from 0.1 to 99 % by weight, preferably from 0.1 to 95 % by weight, of the compound of formula I, 99.9 to 1 % by weight, preferably 99.8 to 5 % by weight, of a solid or liquid adjuvant, and from 0 to 25 % by weight, preferably from 0.1 to 25 % by weight, of a surfactant.
  • compositions may also contain further adjuvants such as stabilizers, antifoams, viscosity regulators, binders or tackifiers as well as fertilizers, micronutrient donors or other formulations for obtaining special effects.
  • Example P-2 5-Chioro-2-(1 -n-butyl-1 -methoxymethyleneamino)thiophene-3-carboxylic-acid propylamide
  • the resulting crude product (yield: 0.8g of 2-n-butyl-3-n-propyl-3H- thieno[2,3-d]-pyrimidine-4-one in the form of a brown liquid) can be used without further purification for the halogenation step.
  • the crude product is added to 100 ml of absolute tetrahydrofurane and under stirring 4.36 g (0.1 mol) NaH in 50 ml abs. THF is carefully added. After stirring for 2 hours at reflux temperature, the solvent is removed in a water-jet vacuum and the residue is taken up in ethyl acetate/water. The water-phase is extracted with additionally ethyl acetate. The organic phase is dried over sodium sulfate and the solvent removed in a water-jet vacuum.
  • NCS N-chlorosuccinimide

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Health & Medical Sciences (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PCT/EP1998/005790 1997-09-12 1998-09-10 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide Ceased WO1999014202A2 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
BR9812439-0A BR9812439A (pt) 1997-09-12 1998-09-10 Novas pirimidin-4-ona e pirimidin-4-tiona como fungicida
US09/508,307 US6277858B1 (en) 1997-09-12 1998-09-10 Pyrimidin-4-one and pyrimidin-4-thione as fungicide
JP2000511753A JP2001516749A (ja) 1997-09-12 1998-09-10 殺菌剤としての新規なピリミジン4−オンおよびピリミジン4−チオン
NZ503261A NZ503261A (en) 1997-09-12 1998-09-10 Fungicidal pyrimidin-4-one and pyrimidin-4-thione derivatives
DE69804981T DE69804981T2 (de) 1997-09-12 1998-09-10 Pyrimidin-4-on und pyrmidin-4-thion als fungicide
AT98951380T ATE216370T1 (de) 1997-09-12 1998-09-10 Pyrimidin-4-on und pyrmidin-4-thion als fungicide
CA002301694A CA2301694A1 (en) 1997-09-12 1998-09-10 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide
PL98339053A PL339053A1 (en) 1997-09-12 1998-09-10 Novel derivatives of 2-oxy-pyrimidyn-4-one and pyrimidin-4-thione as fungicides
IL13477998A IL134779A0 (en) 1997-09-12 1998-09-10 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide
AU97429/98A AU743717B2 (en) 1997-09-12 1998-09-10 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide
DK98951380T DK1015434T3 (da) 1997-09-12 1998-09-10 Ny pyrimidin-4-on og pyrimidin-4-thion som fungicid
KR1020007002578A KR100585571B1 (ko) 1997-09-12 1998-09-10 피리미딘-4-온, 피리미딘-4-티온, 이들의 제조방법 및 당해 화합물을 포함하는 살진균제
EP98951380A EP1015434B1 (en) 1997-09-12 1998-09-10 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9719411.2A GB9719411D0 (en) 1997-09-12 1997-09-12 New Pesticides
GB9719411.2 1997-09-12

Publications (3)

Publication Number Publication Date
WO1999014202A2 true WO1999014202A2 (en) 1999-03-25
WO1999014202A3 WO1999014202A3 (en) 1999-05-14
WO1999014202B1 WO1999014202B1 (en) 1999-06-17

Family

ID=10818960

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/005790 Ceased WO1999014202A2 (en) 1997-09-12 1998-09-10 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide

Country Status (26)

Country Link
US (1) US6277858B1 (https=)
EP (1) EP1015434B1 (https=)
JP (1) JP2001516749A (https=)
KR (1) KR100585571B1 (https=)
CN (1) CN1270593A (https=)
AR (1) AR015439A1 (https=)
AT (1) ATE216370T1 (https=)
AU (1) AU743717B2 (https=)
BR (1) BR9812439A (https=)
CA (1) CA2301694A1 (https=)
DE (1) DE69804981T2 (https=)
DK (1) DK1015434T3 (https=)
EG (1) EG22051A (https=)
ES (1) ES2175804T3 (https=)
GB (1) GB9719411D0 (https=)
GT (1) GT199800142A (https=)
HN (1) HN1998000139A (https=)
HU (1) HUP0002423A3 (https=)
IL (1) IL134779A0 (https=)
NZ (1) NZ503261A (https=)
PL (1) PL339053A1 (https=)
PT (1) PT1015434E (https=)
TR (1) TR200000713T2 (https=)
TW (1) TW429254B (https=)
WO (1) WO1999014202A2 (https=)
ZA (1) ZA988336B (https=)

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000027200A1 (en) * 1998-11-06 2000-05-18 Syngenta Participations Ag FUNGICIDAL COMBINATIONS COMPRISING THIENO[2,3-d]PYRIMIDIN-4-ONE
WO2000031082A1 (en) * 1998-11-06 2000-06-02 Syngenta Participations Ag Pyrimidin-4-enamine as fungicide
WO2002048115A3 (en) * 2000-12-11 2002-09-06 Du Pont Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests
EP0982992B1 (en) * 1997-05-08 2002-09-25 Aventis CropScience UK Limited Use of thienopyrimidines as fungicides
WO2008060611A1 (en) 2006-11-15 2008-05-22 E. I. Du Pont De Nemours And Company Fungicidal mixtures
EP1699767A4 (en) * 2003-12-31 2008-12-03 Scios Inc PROCESS FOR PREPARING PYRIDOPYRIMIDONES
EP1697381A4 (en) * 2003-12-19 2009-03-11 Merck & Co Inc INHIBITORS OF MITOTIC KINESINE
EP2132989A2 (de) 2005-06-09 2009-12-16 Bayer CropScience AG Wirkstoffkombinationen
EP2220935A2 (de) 2003-10-10 2010-08-25 Bayer CropScience AG Synergistische fungizide Wirkstoffkombinationen
EP2255645A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
WO2011006603A2 (de) 2009-07-16 2011-01-20 Bayer Cropscience Ag Synergistische wirkstoffkombinationen mit phenyltriazolen
EP2319313A2 (de) 2004-10-12 2011-05-11 Bayer CropScience AG Fungizide Wirkstoffkombinationen enthaltend Fluoxastrobin und ein weiters Fungizid
EP2356905A1 (de) 2003-10-23 2011-08-17 Bayer Cropscience AG Synergistische fungizide Wirkstoffkombinationen
EP2266962A4 (en) * 2008-03-13 2011-12-07 Guangzhou Inst Biomed & Health COMPOUNDS AS MODULATORS OF ESTROGEN RELATED RECEPTORS AND THEIR USES
CN104151255A (zh) * 2014-07-22 2014-11-19 清华大学 一种多取代喹唑啉亚胺衍生物及其制备方法
US9012360B2 (en) 2009-03-25 2015-04-21 Bayer Intellectual Property Gmbh Synergistic combinations of active ingredients
EP2910126A1 (en) 2015-05-05 2015-08-26 Bayer CropScience AG Active compound combinations having insecticidal properties
WO2017207395A1 (en) 2016-06-02 2017-12-07 Bayer Cropscience Aktiengesellschaft Isothiazolopyridones, processes for their preparation and their use as fungicides
WO2017207462A1 (en) 2016-06-02 2017-12-07 Bayer Cropscience Aktiengesellschaft Isothiazolopyridones, processes for their preparation and their use as herbicides and/or plant growth regulators
DE102007045920B4 (de) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Synergistische Wirkstoffkombinationen
US10588894B2 (en) 2017-06-21 2020-03-17 SHY Therapeutics LLC Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
US10870657B2 (en) 2015-12-22 2020-12-22 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
US12391705B2 (en) 2018-12-19 2025-08-19 Shy Therapeutics, Llc Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021786D0 (en) * 2000-09-05 2000-10-18 Zeneca Ltd Fungicidal formulations
TW200306155A (en) 2002-03-19 2003-11-16 Du Pont Benzamides and advantageous compositions thereof for use as fungicides
KR100967280B1 (ko) * 2002-06-11 2010-07-01 이 아이 듀폰 디 네모아 앤드 캄파니 흰가루병을 방제하는데 유용한 융합된 피리미디논과디니트로페놀 화합물의 혼합물
PT1511380E (pt) * 2002-06-11 2006-12-29 Du Pont Mistura de pirimidinonas fundidas e compostos dinitrofenólicos úteis para controlar oídios
CN1898254A (zh) * 2003-10-30 2007-01-17 马萨诸塞州立大学 肽合成的新偶联剂
DE102005015677A1 (de) 2005-04-06 2006-10-12 Bayer Cropscience Ag Synergistische fungizide Wirkstoffkombinationen
CN100335481C (zh) * 2005-10-11 2007-09-05 华中师范大学 一类具有杀菌除草活性的多取代吡啶并[4,3-d]嘧啶及制备
DE102006023263A1 (de) * 2006-05-18 2007-11-22 Bayer Cropscience Ag Synergistische Wirkstoffkombinationen
WO2008013622A2 (en) 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Fungicidal azocyclic amides
JP5337711B2 (ja) 2007-01-25 2013-11-06 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 殺菌性アミド
US8349870B2 (en) 2008-01-25 2013-01-08 E I Du Pont De Nemours And Company Fungicidal hetercyclic compounds
CN101628913B (zh) * 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
AU2009322486A1 (en) 2008-12-02 2010-06-10 E. I. Du Pont De Nemours And Company Fungicidal heterocyclic compounds
AR075713A1 (es) 2009-03-03 2011-04-20 Du Pont Pirazoles fungicidas
EP2462120A1 (en) 2009-08-07 2012-06-13 E. I. du Pont de Nemours and Company Fungicidal diphenyl-substituted pyridazines
TW201116212A (en) 2009-10-29 2011-05-16 Du Pont Heterobicycle-substituted azolyl benzene fungicides
WO2011051958A1 (en) 2009-10-30 2011-05-05 E.I. Du Pont De Nemours And Company Fungicidal pyrazolones
BR112012016733A2 (pt) 2010-01-07 2015-09-01 Du Pont "composto, composição fungicida e método"
CN102285971B (zh) * 2010-06-21 2013-12-18 中国中化股份有限公司 吡唑基喹唑啉酮类化合物及其应用
WO2012023143A1 (en) 2010-08-19 2012-02-23 E. I. Du Pont De Nemours And Company Fungicidal pyrazoles
CN103130730B (zh) * 2011-11-24 2015-04-08 南开大学 喹唑啉类衍生物及其制备方法、抗hiv活性和抗tmv活性
PL3529246T3 (pl) 2016-10-24 2024-03-25 Fmc Corporation Oksadiazole o działaniu grzybobójczym

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714354A (en) * 1971-07-06 1973-01-30 Pfizer Bronchodilator activity of substituted quinazolinecarboxylic acid esters
BE793594A (fr) * 1972-01-03 1973-07-02 Pfizer Nouvelles 6,7-dimethoxyquinazolines utiles comme analgesiques et tranquillisants
GB8820129D0 (en) * 1988-08-24 1988-09-28 Schering Agrochemicals Ltd Fungicides
SK140295A3 (en) * 1993-05-12 1996-09-04 Du Pont Condensed bicyclic pyrimidinones, fungicidal agents on their base and inhibition method of plant deseases by using them
US5610301A (en) * 1993-07-01 1997-03-11 American Cyanamid Company Process for the regioselective n-alkylation of quinazolinones
BR9609613A (pt) * 1995-07-05 1999-05-25 Du Pont Composto composição fungicida e método de controle de doenças de plantas
BR9809598A (pt) * 1997-05-08 2000-07-04 Agrevo Uk Ltd Uso de compostos, e, composto.

Cited By (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0982992B1 (en) * 1997-05-08 2002-09-25 Aventis CropScience UK Limited Use of thienopyrimidines as fungicides
WO2000027200A1 (en) * 1998-11-06 2000-05-18 Syngenta Participations Ag FUNGICIDAL COMBINATIONS COMPRISING THIENO[2,3-d]PYRIMIDIN-4-ONE
WO2000031082A1 (en) * 1998-11-06 2000-06-02 Syngenta Participations Ag Pyrimidin-4-enamine as fungicide
US6617330B2 (en) 1998-11-06 2003-09-09 Syngenta Participations Ag Pyrimidin-4-enamine as fungicide
WO2002048115A3 (en) * 2000-12-11 2002-09-06 Du Pont Quinazolinones and pyridinopyrimidinones for controlling invertebrate pests
US9288988B2 (en) 2003-10-10 2016-03-22 Fmc Corporation Synergistic fungicidal active substance combinations
US8415274B2 (en) 2003-10-10 2013-04-09 Bayer Cropscience Ag Synergistic fungicidal active substance combinations
US9844220B2 (en) 2003-10-10 2017-12-19 Fmc Corporation Synergistic fungicidal active substance combinations
US9006143B2 (en) 2003-10-10 2015-04-14 Bayer Intellectual Property Gmbh Synergistic fungicidal active substance combinations
EP2220935A2 (de) 2003-10-10 2010-08-25 Bayer CropScience AG Synergistische fungizide Wirkstoffkombinationen
EP2220937A2 (de) 2003-10-10 2010-08-25 Bayer CropScience AG Synergistische fungizide Wirkstoffkombinationen
EP2220936A2 (de) 2003-10-10 2010-08-25 Bayer CropScience AG Synergistische fungizide Wirkstoffkombinationen
EP2220938A2 (de) 2003-10-10 2010-08-25 Bayer CropScience AG Synergistische fungizide Wirkstoffkombinationen
EP2220939A2 (de) 2003-10-10 2010-08-25 Bayer CropScience AG Synergistische fungizide Wirkstoffkombinationen
EP2220940A2 (de) 2003-10-10 2010-08-25 Bayer CropScience AG Synergistische fungizide Wirkstoffkombinationen
EP2229815A2 (de) 2003-10-10 2010-09-22 Bayer CropScience AG Synergistische fungizide Wirkstoffkombinationen
US9049867B2 (en) 2003-10-10 2015-06-09 Bayer Intellectual Property Gmbh Synergistic fungicidal active substance combinations
EP2796043A1 (de) 2003-10-23 2014-10-29 Bayer CropScience AG Synergistische fungizide Wirkstoffkombinationen
EP2364592A1 (de) 2003-10-23 2011-09-14 Bayer Cropscience AG Synergistische fungizide Wirkstoffkombinationen
EP2356906A1 (de) 2003-10-23 2011-08-17 Bayer Cropscience AG Synergistische fungizide Wirkstoffkombinationen
EP2356905A1 (de) 2003-10-23 2011-08-17 Bayer Cropscience AG Synergistische fungizide Wirkstoffkombinationen
EP1697381A4 (en) * 2003-12-19 2009-03-11 Merck & Co Inc INHIBITORS OF MITOTIC KINESINE
EP1699767A4 (en) * 2003-12-31 2008-12-03 Scios Inc PROCESS FOR PREPARING PYRIDOPYRIMIDONES
EP2319313A2 (de) 2004-10-12 2011-05-11 Bayer CropScience AG Fungizide Wirkstoffkombinationen enthaltend Fluoxastrobin und ein weiters Fungizid
EP2258196A2 (de) 2005-06-09 2010-12-08 Bayer CropScience AG Wirkstoffkombinationen
EP2255644A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2255653A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2255652A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2255658A1 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2255659A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2255646A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2255651A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2255650A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2255647A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2255654A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2255655A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2258197A1 (de) 2005-06-09 2010-12-08 Bayer CropScience AG Wirkstoffkombinationen
EP2258198A1 (de) 2005-06-09 2010-12-08 Bayer CropScience AG Wirkstoffkombinationen
EP2255656A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2260710A1 (de) 2005-06-09 2010-12-15 Bayer CropScience AG Wirkstoffkombinationen
EP2260711A2 (de) 2005-06-09 2010-12-15 Bayer CropScience AG Wirkstoffkombinationen
EP2260709A1 (de) 2005-06-09 2010-12-15 Bayer CropScience AG Wirkstoffkombinationen
EP2263463A1 (de) 2005-06-09 2010-12-22 Bayer CropScience AG Wirkstoffkombinationen
EP2263462A1 (de) 2005-06-09 2010-12-22 Bayer CropScience AG Wirkstoffkombinationen
EP2269460A1 (de) 2005-06-09 2011-01-05 Bayer CropScience AG Wirkstoffkombinationen
EP2272369A1 (de) 2005-06-09 2011-01-12 Bayer CropScience AG Wirkstoffkombinationen
EP2272368A1 (de) 2005-06-09 2011-01-12 Bayer CropScience AG Wirkstoffkombinationen
EP2132989A2 (de) 2005-06-09 2009-12-16 Bayer CropScience AG Wirkstoffkombinationen
EP2279664A1 (de) 2005-06-09 2011-02-02 Bayer CropScience AG Wirkstoffkombinationen
EP2255648A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2255649A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2255657A1 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2255645A2 (de) 2005-06-09 2010-12-01 Bayer CropScience AG Wirkstoffkombinationen
EP2253212A1 (de) 2005-06-09 2010-11-24 Bayer CropScience AG Wirkstoffkombinationen
EP2253211A1 (de) 2005-06-09 2010-11-24 Bayer CropScience AG Wirkstoffkombinationen
EP2253210A1 (de) 2005-06-09 2010-11-24 Bayer CropScience AG Wirkstoffkombinationen
EP2253213A1 (de) 2005-06-09 2010-11-24 Bayer CropScience AG Wirkstoffkombinationen
WO2008060611A1 (en) 2006-11-15 2008-05-22 E. I. Du Pont De Nemours And Company Fungicidal mixtures
DE102007045920B4 (de) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Synergistische Wirkstoffkombinationen
EP2266962A4 (en) * 2008-03-13 2011-12-07 Guangzhou Inst Biomed & Health COMPOUNDS AS MODULATORS OF ESTROGEN RELATED RECEPTORS AND THEIR USES
US9012360B2 (en) 2009-03-25 2015-04-21 Bayer Intellectual Property Gmbh Synergistic combinations of active ingredients
WO2011006603A2 (de) 2009-07-16 2011-01-20 Bayer Cropscience Ag Synergistische wirkstoffkombinationen mit phenyltriazolen
CN104151255A (zh) * 2014-07-22 2014-11-19 清华大学 一种多取代喹唑啉亚胺衍生物及其制备方法
EP2910126A1 (en) 2015-05-05 2015-08-26 Bayer CropScience AG Active compound combinations having insecticidal properties
US10870657B2 (en) 2015-12-22 2020-12-22 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
US12168668B2 (en) 2015-12-22 2024-12-17 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
US11560390B2 (en) 2015-12-22 2023-01-24 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
WO2017207395A1 (en) 2016-06-02 2017-12-07 Bayer Cropscience Aktiengesellschaft Isothiazolopyridones, processes for their preparation and their use as fungicides
WO2017207462A1 (en) 2016-06-02 2017-12-07 Bayer Cropscience Aktiengesellschaft Isothiazolopyridones, processes for their preparation and their use as herbicides and/or plant growth regulators
US10933054B2 (en) 2017-06-21 2021-03-02 SHY Therapeutics LLC Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
US10940139B2 (en) 2017-06-21 2021-03-09 SHY Therapeutics LLC Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
US11000515B2 (en) 2017-06-21 2021-05-11 SHY Therapeutics LLC Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
US11026930B1 (en) 2017-06-21 2021-06-08 SHY Therapeutics LLC Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
US11213515B1 (en) 2017-06-21 2022-01-04 SHY Therapeutics LLC Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
US11541041B1 (en) 2017-06-21 2023-01-03 SHY Therapeutics LLC Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease
US10588894B2 (en) 2017-06-21 2020-03-17 SHY Therapeutics LLC Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
US12391705B2 (en) 2018-12-19 2025-08-19 Shy Therapeutics, Llc Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

Also Published As

Publication number Publication date
EP1015434A2 (en) 2000-07-05
ES2175804T3 (es) 2002-11-16
KR100585571B1 (ko) 2006-06-02
NZ503261A (en) 2002-03-28
KR20010023894A (ko) 2001-03-26
HUP0002423A3 (en) 2001-02-28
DE69804981T2 (de) 2002-11-28
CA2301694A1 (en) 1999-03-25
EG22051A (en) 2002-06-30
DK1015434T3 (da) 2002-08-05
CN1270593A (zh) 2000-10-18
HUP0002423A2 (hu) 2000-11-28
PL339053A1 (en) 2000-12-04
PT1015434E (pt) 2002-08-30
ZA988336B (en) 1999-02-12
BR9812439A (pt) 2000-09-26
AU9742998A (en) 1999-04-05
ATE216370T1 (de) 2002-05-15
HN1998000139A (es) 1999-06-02
US6277858B1 (en) 2001-08-21
WO1999014202B1 (en) 1999-06-17
AU743717B2 (en) 2002-01-31
TW429254B (en) 2001-04-11
WO1999014202A3 (en) 1999-05-14
AR015439A1 (es) 2001-05-02
GT199800142A (es) 2000-03-02
GB9719411D0 (en) 1997-11-12
IL134779A0 (en) 2001-04-30
DE69804981D1 (de) 2002-05-23
JP2001516749A (ja) 2001-10-02
EP1015434B1 (en) 2002-04-17
TR200000713T2 (tr) 2000-08-21

Similar Documents

Publication Publication Date Title
EP1015434B1 (en) Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide
US6617330B2 (en) Pyrimidin-4-enamine as fungicide
AU716248B2 (en) Pyrimidin-4-one derivatives as pesticide
US6699818B1 (en) Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
TWI783657B (zh) 苯并磺內醯胺及類似物
US6384040B1 (en) Condensed 4-thioxopyrimidine derivatives as microbicides
JP2002504536A (ja) N−スルホニルおよびn−スルフィニルフェニルグリシナミド
AU734414B2 (en) Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
CZ2000870A3 (cs) Nové deriváty pyrimidin-4-onu a pyrimidin-4- thionu pro použití jako fungicidy, způsob jejich přípravy a prostředky, které je obsahují
MXPA00002413A (en) Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide
CZ2000762A3 (cs) Deriváty pyrimidin-2-oxy-4-onu a pyrimidin-2- oxy-4-thionu
MXPA00002272A (en) Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
EP1115699A1 (en) Pesticidal bis-oxime compounds

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 134779

Country of ref document: IL

Ref document number: 98809037.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: B1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: B1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 97429/98

Country of ref document: AU

Ref document number: 1200000153

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: 1998951380

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2301694

Country of ref document: CA

Ref document number: 2301694

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 503261

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: PV2000-870

Country of ref document: CZ

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/002413

Country of ref document: MX

Ref document number: 09508307

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1020007002578

Country of ref document: KR

Ref document number: 2000/00713

Country of ref document: TR

WWP Wipo information: published in national office

Ref document number: 1998951380

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV2000-870

Country of ref document: CZ

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1020007002578

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 1998951380

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 97429/98

Country of ref document: AU

WWR Wipo information: refused in national office

Ref document number: PV2000-870

Country of ref document: CZ

WWG Wipo information: grant in national office

Ref document number: 1020007002578

Country of ref document: KR